Value for Cord Blood Procalcitonin to Diagnose Early Neonatal Bacterial Infection
NCT ID: NCT02858700
Last Updated: 2016-08-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
550 participants
INTERVENTIONAL
2009-04-30
2015-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Therefore, the common attitude among newborns in many countries remains the achievement of a significant number of additional tests and the establishment, without a prior evidence of infection, intravenous empirical antibiotic therapy for 48 -72h at least in hospitalization. However, the diagnosis of IBNP posteriori, is often reversed. This attitude is:
1. one source to higher health care costs (hospitalization, additional examinations)
2. Selection of the bacterial ecology of the newborn and neonatal services and
3. stress for the newborn and parents
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Utility of Placental/Umbilical Cord Blood in Early Onset Neonatal Sepsis in Very Low Birth Weight Infants
NCT03694613
Neonatal Sepsis Diagnosis: ; PCR Commercial Technique and Blood Culture
NCT03884894
Comparison of Peripheral Perfusion Level Between Two Groups of Newborns According to Their Infectious Status Defined by the Criteria of the Center for Disease Control and Prevention (CDC)
NCT03117907
Characteristics of Cord Blood Immunologic Parameters of Infants <32 Weeks Gestation
NCT00524394
Clinical Evaluation of Early Onset Neonatal Infection
NCT04470596
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
umbilical cord blood procalcitonin
dosage of the umbilical cord blood Procalcitonin for diagnosing of IBNP
dosage of the umbilical cord blood Procalcitonin for diagnosing of IBNP
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
dosage of the umbilical cord blood Procalcitonin for diagnosing of IBNP
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Term \> 34 weeks .
* Presence of at least one of the factors of major or minor infection risk
Exclusion Criteria
* Death in the delivery room
* Corticosteroids prenatally (modification of cytokine production ) .
1 Minute
30 Minutes
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Montpellier
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University hospital of Montpellier
Montpellier, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
8271
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.